Pernix Therapeutics Holdings Inc (PTXTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,446 | -32,097 | -18,584 | -77,141 | -44,718 |
| Depreciation Amortization | 22,657 | 15,729 | 12,049 | 81,910 | 61,278 |
| Income taxes - deferred | N/A | N/A | N/A | -238 | N/A |
| Accounts receivable | 6,487 | 10,042 | 8,311 | 5,412 | 2,361 |
| Accounts payable and accrued liabilities | -293 | -1,739 | -1,904 | N/A | -2,979 |
| Other Working Capital | 2,324 | 6,759 | 5,120 | -3,501 | -2,994 |
| Other Operating Activity | -3,124 | -6,770 | -5,259 | -12,381 | -22,166 |
| Operating Cash Flow | $-25,395 | $-8,076 | $-267 | $-5,939 | $-9,218 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -139 | -98 | -4 | -18 | -5 |
| Net Acquisitions | -69,225 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 446 | 446 | 0 | 2,000 | 0 |
| Investing Cash Flow | $-68,918 | $348 | $-4 | $1,982 | $-5 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 185 | 185 |
| Debt Issued | 50,417 | N/A | N/A | 30,000 | 30,000 |
| Debt Repayment | -5,411 | -5,397 | -5,386 | -18,063 | -17,566 |
| Common Stock Issued | 41,703 | 453 | N/A | 1,979 | 1,123 |
| Other Financing Activity | -807 | -223 | -221 | -13,699 | -13,653 |
| Financing Cash Flow | $85,902 | $-5,167 | $-5,607 | $402 | $89 |
| Exchange Rate Effect | 102 | N/A | N/A | N/A | 0 |
| Beginning Cash Position | 32,820 | 32,820 | 32,820 | 36,375 | 36,375 |
| End Cash Position | 24,511 | 19,925 | 26,942 | 32,820 | 27,241 |
| Net Cash Flow | $-8,309 | $-12,895 | $-5,878 | $-3,555 | $-9,134 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,395 | -8,076 | -267 | -5,939 | -9,218 |
| Capital Expenditure | -139 | -98 | -4 | -18 | -5 |
| Free Cash Flow | -25,534 | -8,174 | -271 | -5,957 | -9,223 |